About

Hyman B. Muss MD is an experienced clinician-scientist, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology at the University of North Carolina School of Medicine, and the Director of the Geriatric Oncology Program at the UNC Lineberger Comprehensive Cancer Center Program. His interest is education and research focused on cancer in older patients and is an internationally recognized leader in this area. His particular interest and research expertise is in the care of breast cancer patients with a focus on the management of older women. He also has a major interest in breast cancer survivorship and long-term toxicity of treatment. After working with his previous UNC colleague, Dr. Ned Sharpless, he is exploring the role of biomarkers of aging and their potential role as predictors of toxicity and survival. Dr. Muss has developed and been PI of multiple clinical and translational trials including lead author of an NCI-sponsored intergroup trial that compared standard care with oral chemotherapy in older women with early stage breast cancer and which for the first time showed the value of chemotherapy in this older populations. He serves as the mentor for medical students, medicine residents, junior faculty, and more recently Geriatric Oncology fellows. He previously co-chaired the Alliance Committee on Cancer in Older Adults. He has been co-chair of the Breast Committee for the CALGB, Chair and a member of the board of Directors of the American Board of Internal Medicine, and a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and the ASCO Foundation. He was awarded the B.J. Kennedy Award in Geriatric Oncology by ASCO, the Susan G. Komen for the Cure Brinker Award for Scientific Distinction in Clinical Research, and an honorary Doctor of Science Degree from his alma mater, Lafayette College. He has served in the U.S. Army in Vietnam where he was awarded the Bronze Star medal.